Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,81 USD | +1,12% | -7,65% | -48,32% |
Vakgebied
Aantal werknemers: 17
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Therapeutics
100,0
%
| 0 | nan % | 12 | 100,0 % | - |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 12 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Charles Theuer
CEO | Chief Executive Officer | 60 | 01-07-06 |
Scott Brown
DFI | Director of Finance/CFO | 43 | 01-08-15 |
James L. Freddo
CTO | Chief Tech/Sci/R&D Officer | 69 | 01-05-20 |
Brenda Marczi
LAW | General Counsel | - | 20-07-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Martin Mattingly
BRD | Director/Board Member | 66 | 26-12-14 |
Director/Board Member | 54 | 19-03-20 | |
Stephen Worland
BRD | Director/Board Member | 66 | 25-02-15 |
Rainer Twiford
BRD | Director/Board Member | 71 | 01-09-08 |
William LaRue
BRD | Director/Board Member | 73 | 01-07-14 |
Charles Theuer
CEO | Chief Executive Officer | 60 | 01-07-06 |
Carol Lam
BRD | Director/Board Member | 64 | 12-10-21 |
Director/Board Member | 60 | 02-03-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 2 275 226 | 2 216 192 ( 97,41 %) | 0 | 97,41 % |
Bedrijfsgegevens
TRACON Pharmaceuticals, Inc.
4350 La Jolla Village Drive Suite 800
92122-1243, San Diego
+
http://www.traconpharma.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-48,32% | 4,12 mln. | |
-4,66% | 86,13 mld. | |
+1,32% | 39,82 mld. | |
-19,27% | 30,42 mld. | |
+57,86% | 25,23 mld. | |
-16,09% | 15,35 mld. | |
-9,14% | 11,95 mld. | |
-17,69% | 11,6 mld. | |
-43,00% | 11,51 mld. | |
+5,24% | 8,71 mld. |
- Beurs
- Aandelen
- Koers TCON
- Onderneming TRACON Pharmaceuticals, Inc.